You have 9 free searches left this month | for more free features.

Tourmaline MM2

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Mandible Tumor Trial in Tanta (Mandibular marginal resection and reconstruction, mandibular osteosynthesis a 2.3mm

Enrolling by invitation
  • Mandible Tumor
  • Mandibular marginal resection and reconstruction
  • mandibular osteosynthesis a 2.3mm reconstruction bone plate
  • Tanta, Gharbia, Egypt
    Tanta University
Oct 19, 2023

Dental Implants Trial in Leioa (Oval section abutment of 2.9 mm, Circular section abutment of 3.3 mm)

Active, not recruiting
  • Dental Implants
  • Oval section abutment of 2.9 mm
  • Circular section abutment of 3.3 mm
  • Leioa, Biscay, Spain
    Department of Stomatology II. UPV/EHU
Dec 27, 2022

Cataract, Corneal Astigmatism, Corneal Incision Contracture Trial (Bimanual 1.4 mm microincision cataract surgery (B-MICS) with

Completed
  • Cataract
  • +2 more
  • Bimanual 1.4 mm microincision cataract surgery (B-MICS) with IOL implantation in a "wound-assisted" technique. In bimanual MICS group a self-sealing 1.4 mm wide incision was created supratemporally
  • +2 more
  • (no location specified)
Aug 19, 2022

Glabellar Frown Lines Trial (onabotulinumtoxinA at a depth of 2mm, onabotulinumtoxinA at a depth of 4mm)

Not yet recruiting
  • Glabellar Frown Lines
  • onabotulinumtoxinA at a depth of 2mm
  • onabotulinumtoxinA at a depth of 4mm
  • (no location specified)
Mar 9, 2023

Multiple Myeloma Trial in Salt Lake City (Budesonide EC, Placebo)

Not yet recruiting
  • Multiple Myeloma
  • Budesonide EC
  • Placebo
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Jan 9, 2023

Clinical Benefits Data of ToggleLoc™ 2.9mm and JuggerLoc™ in

Recruiting
  • Bankart Lesions
  • +6 more
  • ToggleLoc 2.9 mm soft tissue device
  • JuggerLoc soft tissue device
  • Saint Peters, Missouri
  • +2 more
Dec 15, 2022

Relapsed/ Refractory Multiple Myeloma Trial (GC012F)

Not yet recruiting
  • Relapsed/ Refractory Multiple Myeloma
  • GC012F
  • (no location specified)
Apr 28, 2023

Sexually Transmitted Diseases Trial in Berkeley, Los Angeles, Durban (Synthetic Nitrile Condoms (53mm), Synthetic Nitrile

Recruiting
  • Sexually Transmitted Diseases
  • Synthetic Nitrile Condoms (53mm)
  • +2 more
  • Berkeley, California
  • +2 more
Jun 12, 2023

Preterm Birth, Cervical Incompetence, Cervical Insufficiency Trial in Provo (Hannah Cervical Cup (2 mm Delta), Hannah Cervical

Not yet recruiting
  • Preterm Birth
  • +4 more
  • Hannah Cervical Cup (2 mm Delta)
  • +2 more
  • Provo, Utah
    Intermountain Utah Valley Hospital
Aug 20, 2022

Ceramic-on-Ceramic 36mm Acetabular Bearing Insert Post Approval

Active, not recruiting
  • Non-inflammatory Degenerative Joint Disease
  • +3 more
  • COC 36mm
  • Sacramento, California
  • +12 more
Jan 23, 2023

Multiple Myeloma Trial in United States (Daratumumab, Lenalidomide, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Ann Arbor, Michigan
  • +3 more
Jan 19, 2023

Jaw Edentulous Trial in Bern, Belfast (Roxolid short implant, 4 mm length (4), Roxolid short implant, 4 mm length (2))

Active, not recruiting
  • Jaw Edentulous
  • Roxolid short implant, 4 mm length (4)
  • Roxolid short implant, 4 mm length (2)
  • Bern, Switzerland
  • +1 more
Jul 18, 2022

ADHD, Attention Deficit Disorder Trial in Maastricht, Basel (MM-120, Placebo)

Recruiting
  • ADHD
  • Attention Deficit Disorder
  • Maastricht, Netherlands
  • +1 more
Jun 15, 2022

Glenohumeral Joint Degeneration Trial in Rochester (ReUnion System with a Large-Diameter Glenosphere +2 mm offset, ReUnion

Recruiting
  • Glenohumeral Joint Degeneration
  • ReUnion System with a Large-Diameter Glenosphere +2 mm offset
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Mar 7, 2022

Diabetes, Type 2 Trial in Minneapolis, Berlin, Toronto (4 mm x 32G pen needle (Nano), 8mm x 31G pen needle (Short))

Terminated
  • Diabetes Mellitus, Type 2
  • 4 mm x 32G pen needle (Nano)
  • 8mm x 31G pen needle (Short)
  • Minneapolis, Minnesota
  • +2 more
Feb 28, 2022

Thyroid Eye Disease Trial in Miami (TOUR006 - 20 MG, Placebo, TOUR006 - 50 MG)

Recruiting
  • Thyroid Eye Disease
  • TOUR006 - 20 MG
  • +2 more
  • Miami, Florida
    Site - 0103
Oct 11, 2023

Type 2 Diabetes Trial in Aurora, Charlottesville (Glycemic Excursion Minimization (GEM), Medication Management (MM))

Not yet recruiting
  • Type 2 Diabetes
  • Glycemic Excursion Minimization (GEM)
  • Medication Management (MM)
  • Aurora, Colorado
  • +1 more
Mar 1, 2023

Stroke, Stroke, Acute, Oropharyngeal Dysphagia Trial in Mataró (Piperine 150µM + tDCS 2mA, Piperine 1mM + tDCS 2mA, Capsaicin

Recruiting
  • Stroke
  • +3 more
  • Piperine 150μM + tDCS 2mA
  • +2 more
  • Mataró, Barcelona, Spain
    Hospital de Mataró. Consorci Sanitari del Mareme.
Feb 9, 2023

Anxiety Generalized Trial in Lauderhill (MM-120, Placebo)

Recruiting
  • Anxiety Generalized
  • MM-120 (LSD D-Tartrate)
  • Placebo
  • Little Rock, Arkansas
  • +15 more
Jan 27, 2023

Multiple Myeloma Trial in Spain (REGN5458, Daratumumab, Carfilzomib)

Recruiting
  • Multiple Myeloma
  • Athens, Greece
  • +8 more
Nov 30, 2022

High Bleeding Risk, Coronary Artery Disease (CAD), Percutaneous Coronary Intervention (PCI) Trial in Ciudad de México (Drug

Terminated
  • High Bleeding Risk
  • +2 more
  • Drug Eluting Balloon (DEB)
  • Drug Eluting Stents (DES)
  • Ciudad de México, Mexico
    Instituto Nacional de Cardiologia "Ignacio Chávez"
Oct 19, 2021

Influenza Trial in United States (Influenza A/Bethesda/MM2/H1N1 Challenge)

Completed
  • Influenza
  • Influenza A/Bethesda/MM2/H1N1 Challenge
  • Baltimore, Maryland
  • +3 more
Apr 1, 2021

Contraception Trial in Barcelona (Levonorgestrel (13,5 mg) intrauterine device, Cooper (380mm2) intrauterine device)

Completed
  • Contraception
  • Levonorgestrel (13,5 mg) intrauterine device
  • Cooper (380mm2) intrauterine device
  • Barcelona, Spain
    Hospital de la Santa Creu i Sant Pau
Oct 22, 2021

Multiple Myeloma (MM), DLBCL, Not Otherwise Specified, Double Hit Lymphoma Trial in Spain (IDP-121)

Recruiting
  • Multiple Myeloma (MM)
  • +5 more
  • Santander, Cantabria, Spain
  • +4 more
Jun 19, 2023

HIV Trial in Houston (Aldesleukin)

Completed
  • HIV Infections
  • Houston, Texas
    Thomas Street Clinic C605-020 CRS
Oct 27, 2021